CareDx Raises FY26 Rev Guidance To $520M-$530M Prior $490M-$500M; Raises Adj. EBITDA Guidance To $90M-$100M Prior $66M-$78M

Loading news article.

CareDx Raises FY26 Rev Guidance To $520M-$530M Prior $490M-$500M; Raises Adj. EBITDA Guidance To $90M-$100M Prior $66M-$78M | WAPE

Article summary